Activated human T lymphocytes express a functional C3a receptor

Journal of Immunology

Volumn 165, Issue 11, 2000, Pages 6599-6605

  Werfel, T ^a   Kirchhoff, K ^a   Wittmann, M ^a   Begemann, G ^a   Kapp, A ^a   Heidenreich, F ^a   Gotze, O ^a   Zwirner, J ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CALCIUM; COMPLEMENT COMPONENT C3 RECEPTOR; COMPLEMENT COMPONENT C3A; INTERFERON;

ARTICLE; ATOPIC DERMATITIS; CALCIUM TRANSPORT; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR CLONING; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN INFLAMMATION; T LYMPHOCYTE ACTIVATION;

EID: 0034541183     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.11.6599     Document Type: Article

References (37)

1. Structure and function of C3a anaphylatoxin
2. Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a
3. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells
4. Chronic myelogenous leukemia-derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a
5. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway
6. C3a and C5a stimulate chemotaxis of human mast cells
7. The human mast cell line HMC-1 binds and responds to C3a but not C3a(desArg)
8. C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils
9. Degranulation from human eosinophils stimulated with C3a and C5a
10. C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation
11. Comparison of C3a- and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo
12. Involvement of C3a and C5a in interleukin-8 secretion by human polymorphonuclear cells in response to capsular material of Cryptococcus neoformans
13. C3a activates the respiratory burst in human polymorphonuclear neutrophilic leukocytes via pertussis toxin-sensitive G-proteins
14. The role of prostaglandins in C3a-mediated suppression of human in vitro polyclonal antibody responses
15. Blood- and skin-derived monocytes/macrophages respond to C3a but not to C3a(desArg) with a transient release of calcium via a pertussis toxin-sensitive signal transduction pathway
16. Anaphylatoxin-mediated regulation of the immune response. I. C3a-mediated suppression of human and murine humoral immune responses
17. Molecular cloning and characterization of the human anaphylatoxin C3a receptor
18. Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells
19. cDNA cloning of a novel G protein-coupled receptor with a large extracellular loop structure
20. C3a(desArg) does not bind to and signal through the human C3a receptor
21. + cells and react with a desmosomal antigen in human skin
22. Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T cell responses to birch pollen antigens
23. Evaluation of C3a receptor expression on human leucocytes by the use of novel monoclonal antibodies
24. C5a suppresses the production of IL-12 by IFN-γ-primed and lipopolysaccharide-challenged human monocytes
25. Modulation of C3a activity: Internalization of the human C3a receptor and its inhibition by C5a
26. The human C3a receptor is expressed on neutrophils and monocytes, but not on B or T lymphocytes
27. Properdin, a positive regulator of complement activation, is expressed in human T cell lines and peripheral blood T cells
28. Synthesis of the third component of complement (C3) by lectin-activated and HTLV-infected human T cells
29. The neglected role of type I interferon in the T cell response: Implications for its clinical use
30. The third component of complement inhibits human lymphocyte blastogenesis
31. Complement inhibits immune responses: C3 preparations inhibit the generation of human cytotoxic T lymphocytes
32. + suppressor T cells
33. Regulation of B cell functions by C3a and C3a(desArg): Suppression of TNF-α, IL-6, and the polyclonal immune response
34. Human T cells express the C5a receptor and are chemoattracted to C5a
35. C5a anaphylatoxin and its seven transmembrane-segment receptor
36. Induction of interleukin-1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface C5a receptors
37. Anaphylatoxin-mediated regulation of the immune response: C5a-mediated enhancement of human humoral and T cell-mediated immune responses